Evidence map›Paper›PMID 24651768›Full record

ArticlePLoS neglected tropical diseases2014

Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.

Chrissy H Roberts, Sandra Molina, Pateh Makalo, Hassan Joof, Emma M Harding-Esch, Sarah E Burr, David C W Mabey, Robin L Bailey, Matthew J Burton, Martin J Holland

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Medicine and pharmacy reports · 2023
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Immunopathogenesis of Chlamydial Infections.Current topics in microbiology and immunology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Chrissy H RobertsClinical Research Department, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Sandra MolinaClinical Research Department, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Pateh MakaloMedical Research Council Unit, The Gambia, Atlantic Boulevard, Fajara, The Gambia.
Hassan JoofMedical Research Council Unit, The Gambia, Atlantic Boulevard, Fajara, The Gambia.
Emma M Harding-EschClinical Research Department, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Sarah E BurrClinical Research Department, London School of Hygiene and Tropical Medicine, London, United Kingdom; Medical Research Council Unit, The Gambia, Atlantic Boulevard, Fajara, The Gambia.
David C W MabeyClinical Research Department, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Robin L BaileyClinical Research Department, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Matthew J BurtonInternational Centre for Eye Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Martin J HollandClinical Research Department, London School of Hygiene and Tropical Medicine, London, United Kingdom; Medical Research Council Unit, The Gambia, Atlantic Boulevard, Fajara, The Gambia.
London School of Hygiene & Tropical Medicine · GBMRC Unit the Gambia · GM

Funding

Wellcome Trust 079246/Z/06/ZWellcome Trust 100714Wellcome Trust 98481Wellcome Trust GR079246MA
6 · The paper itself

Abstract

backgroundChlamydia trachomatis is globally the predominant infectious cause of blindness and one of the most common bacterial causes of sexually transmitted infection. Infections of the conjunctiva cause the blinding disease trachoma, an immuno-pathological disease that is characterised by chronic conjunctival inflammation and fibrosis. The polymorphic Killer-cell Immunoglobulin-like Receptors (KIR) are found on Natural Killer cells and have co-evolved with the Human Leucocyte Antigen (HLA) class I system. Certain genetic constellations of KIR and HLA class I polymorphisms are associated with a number of diseases in which modulation of the innate responses to viral and intracellular bacterial pathogens is central. METHODOLOGY: A sample of 134 Gambian pedigrees selected to contain at least one individual with conjunctival scarring in the F1 generation was used. Individuals (n = 830) were genotyped for HLA class I and KIR gene families. Family Based Association Tests and Case Pseudo-control tests were used to extend tests for transmission disequilibrium to take full advantage of the family design, genetic model and phenotype. PRINCIPLE

findingsWe found that the odds of trachomatous scarring increased with the number of genome copies of HLA-C2 (C1/C2 OR = 2.29 BHP-value = 0.006; C2/C2 OR = 3.97 BHP-value = 0.0004) and further increased when both KIR2DL2 and KIR2DL3 (C2/C2 OR = 5.95 BHP-value = 0.006) were present.

conclusionsTo explain the observations in the context of chlamydial infection and trachoma we propose a two-stage model of response and disease that balances the cytolytic response of KIR expressing NK cells with the ability to secrete interferon gamma, a combination that may cause pathology. The data presented indicate that HLA-C genotypes are important determinants of conjunctival scarring in trachoma and that KIR2DL2/KIR2DL3 heterozygosity further increases risk of conjunctival scarring in individuals carrying HLA-C2.

Indexed as

Genetic Predisposition to DiseaseAdolescentAdultAgedAged, 80 and overChildChild, PreschoolChlamydia trachomatisCicatrixConjunctivaFemaleGambiaGenetic Association StudiesGenotypeHeterozygoteHLA-C AntigensHLA-C AntigensKIR2DL2 protein, humanKIR2DL3 protein, humanLigandsReceptors, KIR2DL2Receptors, KIR2DL3

Identifiers

PMID24651768
PMCPMC3961204
OpenAlexW1989506318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.